Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Renal Failure
  Free Subscription

Articles published in
Kidney Int
    December 2027
  1. FERRO CJ, Townend JN
    Atherosclerosis in chronic kidney disease-early prevention is better than late treatment.
    Kidney Int. 2027 Dec 5:S0085-2538(25)00954-8. doi: 10.1016/j.kint.2025.
    >> Share

  2. MASSY ZA
    The management of chronic kidney disease-associated cardiovascular complications should go beyond the management of traditional cardiovascular risk factors.
    Kidney Int. 2027 Dec 5:S0085-2538(25)00953-6. doi: 10.1016/j.kint.2025.
    >> Share

    August 2026
  3. TANNOR EK, Luyckx VA, Abdelsalam M, Jerbi M, et al
    The AFRAN Prevention and Advocacy Group advocates for chronic kidney disease care: fulfilling the right to kidney health in Africa.
    Kidney Int. 2026;110:274-277.
    >> Share

    July 2026
  4. WAGNER S, A Massy Z, Koppe L
    From gut to uremic toxins: a not-so-innocent alliance between microbiota and enterocytes in chronic kidney disease.
    Kidney Int. 2026 Jul 21:S0085-2538(26)00594-6. doi: 10.1016/j.kint.2026.
    >> Share

    June 2026
  5. XIAO D, Ning F, Lei H, Liu J, et al
    Peritoneal dialysis in a patient with extensive burn scarring.
    Kidney Int. 2026 Jun 26:S0085-2538(26)00510-7. doi: 10.1016/j.kint.2026.
    >> Share

  6. LOGAN B, Viecelli AK, Johnson DW, Comans T, et al
    A cluster randomized controlled trial (GOAL trial) evaluated a comprehensive geriatric assessment for frail older people with chronic kidney disease.
    Kidney Int. 2026 Jun 18:S0085-2538(26)00495-3. doi: 10.1016/j.kint.2026.
    >> Share

  7. ANFT M, Paniskaki K, Franz D, Skrzypczyk S, et al
    Respiratory syncytial virus vaccination induces delayed but robust humoral and cellular immunity in patients receiving hemodialysis.
    Kidney Int. 2026 Jun 16:S0085-2538(26)00473-4. doi: 10.1016/j.kint.2026.
    >> Share

  8. MOONEN L, Conte C, Van Campen E, Peired AJ, et al
    Strategic timing of contralateral nephrectomy after ischemic acute kidney injury prevents chronic kidney disease by enhancing progenitor proliferation, attenuating polyploidization and reshaping the immune response.
    Kidney Int. 2026 Jun 15:S0085-2538(26)00432-1. doi: 10.1016/j.kint.2026.
    >> Share

  9. LIU J, Yang X, Zhang W, Wang J, et al
    The Calcified Cocoon: Obstructive Peritoneal Sclerosis in Peritoneal Dialysis.
    Kidney Int. 2026 Jun 10:S0085-2538(26)00430-8. doi: 10.1016/j.kint.2026.
    >> Share

  10. GATELY R, Wong G, Teixeira-Pinto A
    Techniques to predict survival outcomes in nephrology: basics and traditional methods.
    Kidney Int. 2026;109:1137-1147.
    >> Share

    May 2026
  11. SHALL A, Hammer F, Vanhove T, Channaoui A, et al
    Giant renal allograft aneurysm: late detection and embolization.
    Kidney Int. 2026 May 20:S0085-2538(26)00393-5. doi: 10.1016/j.kint.2026.
    >> Share

  12. RIKIHISA T, Yoshimura Y, Oba Y, Hasegawa E, et al
    When kidneys can't be biopsied, skin biopsy identifies SLE relapse on dialysis.
    Kidney Int. 2026;109:1041.
    >> Share

  13. SUN XJ, Ma TT, Wang HY, Liu JG, et al
    Dynamic computed tomography peritoneography for the paracolic gutter leakage in peritoneal dialysis.
    Kidney Int. 2026;109:1040.
    >> Share

    April 2026
  14. KENTRUP D, Thomas JJ, Courbon G, Wang X, et al
    Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophy.
    Kidney Int. 2026 Apr 27:S0085-2538(26)00309-1. doi: 10.1016/j.kint.2026.
    >> Share

  15. CAZA TN, Charu V, Dai DF, Davis VG, et al
    Clinical and Histologic Predictors of Non-Diabetic Kidney Disease in Patients with Diabetes Mellitus.
    Kidney Int. 2026 Apr 23:S0085-2538(26)00305-4. doi: 10.1016/j.kint.2026.
    >> Share

  16. NAKAGAWA Y, Onozawa Y, Kanai G, Nakamura M, et al
    Catheter malposition in a peritoneal dialysis patient with Chilaiditi sign.
    Kidney Int. 2026;109:801.
    >> Share

  17. RAJU S, Gollapudi SS, Senthilkumar T, Sunitha VC, et al
    The Case | A young man with medullary nephrocalcinosis and chronic kidney disease.
    Kidney Int. 2026;109:803-804.
    >> Share

    March 2026
  18. TOYE C, Brown PA, Canney M
    Migrating peritoneal dialysis catheter into an inguinal hernia.
    Kidney Int. 2026 Mar 6:S0085-2538(26)00062-1. doi: 10.1016/j.kint.2025.
    >> Share

  19. BNAYA A, Gomez D, Libdeh OA, Elayan N, et al
    Brown tumor of the patella in a long-term hemodialysis patient.
    Kidney Int. 2026;109:612.
    >> Share

  20. NASSIRI M, Parra-Londono F, Lopez-Baez V, Arango-Sancho P, et al
    Is it time to add a fifth pillar to the physical examination in pediatric dialysis?
    Kidney Int. 2026;109:608-609.
    >> Share

  21. LETOURNEAU P
    Causal claims require defined interventions: a note on the EQUAL chronic kidney disease-mineral and bone disorder analysis.
    Kidney Int. 2026;109:606-607.
    >> Share

  22. BIKBOV B
    Challenges in revealing the true incidence of end-stage kidney disease in the elderly population.
    Kidney Int. 2026;109:603-604.
    >> Share

  23. DELANAYE P, Mariat C
    Percentiles of estimating glomerular filtration rate: a new personalized tool for detection of chronic kidney disease.
    Kidney Int. 2026;109:436-438.
    >> Share

    February 2026
  24. BARRACLOUGH KA, Berman-Parks N, Jha V, Piccoli GB, et al
    Green Dialysis: Environmentally Sustainable Care, Growth, and Innovation: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2026 Feb 17:S0085-2538(26)00079-7. doi: 10.1016/j.kint.2026.
    >> Share

  25. TING YT, Ooi JD
    Hybrid CARs: rewiring macrophage signaling for targeted therapy in acute and chronic kidney inflammation.
    Kidney Int. 2026 Feb 12:S0085-2538(26)00070-0. doi: 10.1016/j.kint.2026.
    >> Share

  26. CHANG FC, Lin SL
    Angiopoietin-2 inhibition and TIE2 reactivation in chronic kidney disease: the next step forward.
    Kidney Int. 2026 Feb 5:S0085-2538(26)00067-0. doi: 10.1016/j.kint.2025.
    >> Share

  27. FU SS, Tian ZX
    Pericatheter vascular calcification in a long-term hemodialysis patient.
    Kidney Int. 2026;109:401.
    >> Share

  28. KATO A, Shirai Y, Aihara Y, Miura K, et al
    Scurvy diagnosed in a patient undergoing peritoneal dialysis.
    Kidney Int. 2026;109:399.
    >> Share

  29. BERTRAND J, Dufour I, Lhommel R, Goffin E, et al
    Heart-shaped pelvic abscess in a patient undergoing peritoneal dialysis: a Valentine's Day surprise.
    Kidney Int. 2026;109:398.
    >> Share

    January 2026
  30. MILDERS J, Janse RJ, Bos WJW, Caskey FJ, et al
    A predictor finding study found patient-reported outcomes improve the prediction of mortality of incident dialysis patients.
    Kidney Int. 2026 Jan 21:S0085-2538(25)00677-5. doi: 10.1016/j.kint.2025.
    >> Share

  31. KUPSCH C, Tsou S, Martin F, Wolff von Gudenberg R, et al
    Eligibility, Timing and Organ Quality: Indications and Outcomes of Kidney Transplantation in Older Patients.
    Kidney Int. 2026 Jan 21:S0085-2538(26)00052-9. doi: 10.1016/j.kint.2025.
    >> Share

  32. YANG Y, Creon A, Levey AS, Faucon AL, et al
    Population-based estimated Glomerular Filtration Rate distributions and associated health outcomes provide opportunities for early identification of and primary prevention of chronic kidney disease.
    Kidney Int. 2026 Jan 16:S0085-2538(25)00989-5. doi: 10.1016/j.kint.2025.
    >> Share


  33. KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD).
    Kidney Int. 2026;109.
    >> Share

  34. BABITT JL, Berns JS, Bozkurt B, Cheung Khedairy RS, et al
    Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD).
    Kidney Int. 2026;109:44-56.
    >> Share

    December 2025
  35. SIRIWARDANA A, Tangri N, Neuen B, Jardine M, et al
    UTILIZING RISK PREDICTION MODELS FOR OLDER PATIENTS WITH CHRONIC KIDNEY DISEASE.
    Kidney Int. 2025 Dec 24:S0085-2538(25)01015-4. doi: 10.1016/j.kint.2025.
    >> Share

    November 2025
  36. HUGHES A, Gonzalez AM, van Zwieten A, Guha C, et al
    Establishing a core outcome measure for life participation in children with chronic kidney disease: a Standardised Outcomes in Nephrology - children and adolescents with chronic kidney disease (SONG-Kids) consensus workshop report.
    Kidney Int. 2025 Nov 25:S0085-2538(25)00887-7. doi: 10.1016/j.kint.2025.
    >> Share

  37. CHRYSOSTOMOU C, Faustini F, Segelmark M, Carrero JJ, et al
    A national cohort study examined the risk of severe infection and infection-related mortality in patients with chronic kidney disease with lupus nephritis in comparison to other chronic kidney disease etiologies.
    Kidney Int. 2025 Nov 21:S0085-2538(25)00883-X. doi: 10.1016/j.kint.2025.
    >> Share

  38. TANGRI N, Neuen BL, Cherney DZ, Tuttle KR, et al
    From Progression to Remission: A New Paradigm for Success in Chronic Kidney Disease.
    Kidney Int. 2025 Nov 6:S0085-2538(25)00847-6. doi: 10.1016/j.kint.2025.
    >> Share

  39. SHUE I, Cherian R, Walker X, Slater K, et al
    The Case | Refractory hyperkalemia after ileostomy in a hemodialysis patient.
    Kidney Int. 2025;108:955-956.
    >> Share

  40. COZZI E
    Delisting of HLA antigens as a possible strategy to enable transplantation in highly sensitized patients with a cPRA >/= 99.9.
    Kidney Int. 2025;108:748-751.
    >> Share

    October 2025
  41. SHROFF R, Schaefer F
    Optimizing cardiovascular outcomes in pediatric dialysis.
    Kidney Int. 2025 Oct 25:S0085-2538(25)00840-3. doi: 10.1016/j.kint.2025.
    >> Share

  42. FURTH SL, Colhoun HM, Kanbay M, Kukla A, et al
    The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2025 Oct 9:S0085-2538(25)00774-4. doi: 10.1016/j.kint.2025.
    >> Share

  43. HARTZ W, Kinniry P
    Hypertriglyceridemia causing dialysis filter lipid deposition.
    Kidney Int. 2025;108:718.
    >> Share

  44. RAVI KS, Mc Causland FR
    Where next for potassium binders in hemodialysis?
    Kidney Int. 2025;108:534-536.
    >> Share

  45. WONG G, Teixeira-Pinto A
    Redefining kidney failure: broadening metrics to realize equity in kidney care.
    Kidney Int. 2025;108:532-533.
    >> Share

    September 2025
  46. SMOYER WE, Gillespie BS, Oni L, Nester C, et al
    STRATEGIES FOR THE DEVELOPMENT OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS FOR KIDNEY PROTECTION IN PEDIATRIC CHRONIC KIDNEY DISEASE: PROCEEDINGS OF A WORKSHOP MEETING IN JULY 2023.
    Kidney Int. 2025 Sep 24:S0085-2538(25)00747-1. doi: 10.1016/j.kint.2025.
    >> Share

  47. CIROVIC A, Cirovic A
    Beyond fibroblast growth factor 23-fibroblast growth factor receptor 4: could aldosterone-driven iron deficiency impact cardiac remodeling in chronic kidney disease?
    Kidney Int. 2025;108:499.
    >> Share

    August 2025
  48. ITO H, Sato T, Sato F, Taniguchi Y, et al
    The Case | Acute neck swelling in a patient undergoing dialysis.
    Kidney Int. 2025;108:335-336.
    >> Share

  49. PIRBUCCUS M, Dufour I, Akachar Y, Goffin E, et al
    "Strawberry milkshake" effluent in a patient undergoing peritoneal dialysis.
    Kidney Int. 2025;108:331.
    >> Share

  50. PICCOLI GB, Orozco A, Shemies R, Attini R, et al
    Postpartum counseling and interventions to reduce the risk of chronic kidney disease: back to the future.
    Kidney Int. 2025;108:160-166.
    >> Share

    July 2025
  51. MURAKAMI N, Blosser CD, Webber AB, Gupta G, et al
    Management recommendations for kidney transplantation in patients with plasma cell dyscrasia.
    Kidney Int. 2025 Jul 28:S0085-2538(25)00576-9. doi: 10.1016/j.kint.2025.
    >> Share

  52. FISHBANE S, Dember LM, Jadoul M, Kovesdy CP, et al
    The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis.
    Kidney Int. 2025 Jul 4:S0085-2538(25)00509-5. doi: 10.1016/j.kint.2025.
    >> Share

  53. TEMPLE K, Lester R, Sinclair N, Owen K, et al
    Indigenous spirituality and cultural knowledges provide strength and resilience to Aboriginal people with chronic kidney disease.
    Kidney Int. 2025;108:2-4.
    >> Share

  54. AGARWAL R
    Steroidal or nonsteroidal mineralocorticoid receptor antagonists for reducing cardiovascular burden in chronic kidney disease.
    Kidney Int. 2025;108:11-14.
    >> Share

    June 2025
  55. RAILLON LA, Florens N, Payelle F, Martin M, et al
    Medium chain fatty acids are potent binding competitors to improve protein-bound uremic toxin clearance during hemodialysis.
    Kidney Int. 2025 Jun 25:S0085-2538(25)00492-2. doi: 10.1016/j.kint.2025.
    >> Share

  56. ORTIZ A, Arreola Guerra JM, Chan JCN, Jha V, et al
    Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2025 Jun 18:S0085-2538(25)00334-5. doi: 10.1016/j.kint.2025.
    >> Share

  57. CUCCHIARI D, Mancebo-Sierra E, Caro JL, Meneghini M, et al
    A multicenter prospective cohort study evaluating impact of an active delisting strategy to enable kidney transplantation in wait-listed candidates with calculated Panel Reactive Antibody >/= 99.9.
    Kidney Int. 2025 Jun 6:S0085-2538(25)00427-2. doi: 10.1016/j.kint.2025.
    >> Share

  58. RIZZOLO K, Villegas L, Cervantes L
    The national landscape of kidney transplantation for undocumented immigrants: advancing kidney transplantation equity.
    Kidney Int. 2025;107:976-979.
    >> Share

  59. CHARYTAN DM, Winkelmayer WC, Granger CB, Middleton JP, et al
    Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients
    Kidney Int. 2025;107:1123.
    >> Share

    May 2025
  60. MITROFANOVA A, Fontanella AM, Molina J, Zhang G, et al
    The enzyme SMPDL3b in podocytes decouples proteinuria from chronic kidney disease progression in experimental Alport Syndrome.
    Kidney Int. 2025 May 30:S0085-2538(25)00407-7. doi: 10.1016/j.kint.2025.
    >> Share

  61. MUREA M, Torreggiani M, Deira J, Sirich TL, et al
    From Niche to Norm: A Multi-Action Plan to Close Gaps and Mainstream Incremental Hemodialysis.
    Kidney Int. 2025 May 20:S0085-2538(25)00404-1. doi: 10.1016/j.kint.2025.
    >> Share

  62. DE BOER IH, Caramori ML, Chan JCN, Heerspink HJL, et al
    GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease-a KDIGO commentary.
    Kidney Int. 2025;107:767-771.
    >> Share

    April 2025
  63. LI F, Lan Q, Wang Y, Xiong J, et al
    Single-cell analysis of proximal tubular cells with different DNA content reveals functional heterogeneity in the acute kidney injury to chronic kidney disease transition.
    Kidney Int. 2025 Apr 21:S0085-2538(25)00332-1. doi: 10.1016/j.kint.2025.
    >> Share

  64. ERICKSON KF, Fotheringham J
    Is online hemodiafiltration a cost-effective alternative to conventional hemodialysis?
    Kidney Int. 2025;107:602-605.
    >> Share

    March 2025
  65. STACK AG
    Can we crystallize the role of urate-lowering treatment in chronic kidney disease?
    Kidney Int. 2025;107:394-396.
    >> Share

  66. JENSEN M, Jensen BL
    Soluble guanylate cyclase as a direct target for pharmacologic mitigation of chronic kidney disease.
    Kidney Int. 2025;107:391-394.
    >> Share

    February 2025
  67. BONNIN-MARQUEZ A, Jankowski J, Maas SL, Hermann J, et al
    Guanidinylation compromises the anti-inflammatory and anti-oxidative properties of apolipoprotein A-I in chronic kidney disease progression.
    Kidney Int. 2025 Feb 24:S0085-2538(25)00171-1. doi: 10.1016/j.kint.2025.
    >> Share

  68. ZHU D, Judge PK, Wanner C, Haynes R, et al
    THE PREVENTION AND MANAGEMENT OF CHRONIC KIDNEY DISEASE AMONG PATIENTS WITH METABOLIC SYNDROME.
    Kidney Int. 2025 Feb 20:S0085-2538(25)00141-3. doi: 10.1016/j.kint.2024.
    >> Share

  69. MENON G, Metoyer GT, Li Y, Chen Y, et al
    A national registry study evaluated the landscape of kidney transplantation among presumed unauthorized immigrants in the United States.
    Kidney Int. 2025 Feb 14:S0085-2538(25)00088-2. doi: 10.1016/j.kint.2025.
    >> Share

  70. FUCHS MAA, Burke EJ, Latic N, Murray S, et al
    Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease.
    Kidney Int. 2025 Feb 7:S0085-2538(25)00087-0. doi: 10.1016/j.kint.2025.
    >> Share

  71. HSU SN, Stephen LA, Phadwal K, Dillon S, et al
    Mitochondrial dysfunction and mitophagy blockade contribute to renal osteodystrophy in chronic kidney disease-mineral bone disorder.
    Kidney Int. 2025 Feb 6:S0085-2538(25)00085-7. doi: 10.1016/j.kint.2025.
    >> Share

  72. HUGHES A, Scholes-Robertson N, Coghlan D, Wu R, et al
    Identifying strategies for disseminating research to patients with chronic kidney disease and caregivers: a workshop report.
    Kidney Int. 2025 Feb 6:S0085-2538(25)00083-3. doi: 10.1016/j.kint.2025.
    >> Share

    January 2025
  73. SCHOUTEN AEM, Fischer F, Blankestijn PJ, Vernooij RWM, et al
    A health economic evaluation of the multinational, randomized controlled CONVINCE trial - cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis.
    Kidney Int. 2025 Jan 21:S0085-2538(25)00068-7. doi: 10.1016/j.kint.2024.
    >> Share

  74. KETTELER M, Evenepoel P, Holden RM, Isakova T, et al
    Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2025 Jan 10:S0085-2538(24)00810-X. doi: 10.1016/j.kint.2024.
    >> Share

  75. HOLE B, Coast J, Caskey FJ, Selman LE, et al
    A choice experiment of older patients' preferences for kidney failure treatments.
    Kidney Int. 2025;107:130-142.
    >> Share

  76. WATANABE S, Sawa N, Hiramatsu R, Oba Y, et al
    The Case | A patient with chronic kidney disease and new-onset heart failure.
    Kidney Int. 2025;107:195-196.
    >> Share

    December 2024
  77. MIMURA I, Chen Z, Natarajan R
    Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes.
    Kidney Int. 2024 Dec 24:S0085-2538(24)00918-9. doi: 10.1016/j.kint.2024.
    >> Share

  78. HANOUNEH M, Stewart S, Aktay R, Fang AS, et al
    Chylothorax and chylopericardium in a dialysis patient.
    Kidney Int. 2024;106:1190.
    >> Share

  79. BOBOT M, Burtey S
    New insights into mechanisms underlying cognitive impairment in chronic kidney disease.
    Kidney Int. 2024;106:1020-1022.
    >> Share

    November 2024
  80. AMINI M, Frisch J, Jost P, Sarakpi T, et al
    Purinergic receptor P2X7 regulates interleukin-1alpha mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner.
    Kidney Int. 2024 Nov 19:S0085-2538(24)00798-1. doi: 10.1016/j.kint.2024.
    >> Share

  81. VAN DEN BERG CW, Dumas SJ, Little MH, Rabelink TJ, et al
    Challenges in maturation and integration of kidney organoids for stem cell-based renal replacement therapy.
    Kidney Int. 2024 Nov 19:S0085-2538(24)00806-8. doi: 10.1016/j.kint.2024.
    >> Share

  82. KO TY, Wu CC, Hsieh MY, Yang CW, et al
    A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access.
    Kidney Int. 2024 Nov 15:S0085-2538(24)00792-0. doi: 10.1016/j.kint.2024.
    >> Share

  83. GHANG B, Park J, Lee JS, Lim JS, et al
    Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy.
    Kidney Int. 2024 Nov 15:S0085-2538(24)00789-0. doi: 10.1016/j.kint.2024.
    >> Share

  84. GEORGERY H, Lengele JP, Leflot S, Gillion V, et al
    Recurrent iodine-induced sialadenitis in a patient undergoing hemodialysis: is this really ineluctable?
    Kidney Int. 2024;106:997.
    >> Share

  85. HAMDAN H, Roshanravan B
    Dialysis modality and quality of life: more answers yet more questions.
    Kidney Int. 2024;106:792-794.
    >> Share

  86. SHAREEF Z, Spradling M, Blair P, Quinones-Vargas I, et al
    Appendicitis associated with sevelamer use in a patient receiving peritoneal dialysis.
    Kidney Int. 2024;106:1000.
    >> Share

  87. YANAGI T, Kikuchi H, Takeuchi K, Susa K, et al
    ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease.
    Kidney Int. 2024;106:887-906.
    >> Share

    October 2024
  88. IKIZLER TA, Drueke TB, Floege J, Wong G, et al
    Avoiding Arrythmias by Personalizing Dialysate Concentration: A Case for Precision Medicine in Dialysis Patients.
    Kidney Int. 2024 Oct 22:S0085-2538(24)00721-X. doi: 10.1016/j.kint.2024.
    >> Share

  89. CHARYTAN DM, Winkelmayer WC, Granger CB, Middleton JP, et al
    Effects of dialysate potassium concentration of 3.0mEq/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0mEq/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia.
    Kidney Int. 2024 Oct 22:S0085-2538(24)00722-1. doi: 10.1016/j.kint.2024.
    >> Share

  90. BAJAJ A, Arora M, Bhatt U
    The Case | Dark dialysate after colonoscopy.
    Kidney Int. 2024;106:761-762.
    >> Share

  91. SHARMA Y, Tiwari V, Tyagi V, Bhargava V, et al
    CAPD catheter obstruction by fallopian tubes.
    Kidney Int. 2024;106:760.
    >> Share

  92. CHEN WLJ, Fung KFK, Chan EY
    Nephronophthisis-associated ciliopathy with brachydactyly, medullary cysts, and chronic kidney disease.
    Kidney Int. 2024;106:759.
    >> Share

    September 2024
  93. BISHOP NC
    Unpicking the multi-omic response to endurance training: relevance for exercise benefits in chronic kidney disease.
    Kidney Int. 2024 Sep 18:S0085-2538(24)00646-X. doi: 10.1016/j.kint.2024.
    >> Share

  94. TONG KC, Wee KW
    Cardiovascular disease as a risk factor for frailty in dialysis patients.
    Kidney Int. 2024;106:537-538.
    >> Share

  95. GARG AX, Young A
    Improving the management of chronic kidney disease in primary care by enhancing laboratory reports with additional information and follow-up procedures.
    Kidney Int. 2024;106:366-368.
    >> Share

    August 2024
  96. BERGERON NAD, Candellier A, Rousseau-Gagnon M, Mac-Way F, et al
    Unusual cause of retroperitoneal leak in a patient undergoing peritoneal dialysis.
    Kidney Int. 2024;106:321.
    >> Share

  97. TOUSSAINT ND, Badve SV
    Normalizing serum phosphate based on association, not causation? Lessons in dialysis should have taught us not to fix what we can't prove is broken.
    Kidney Int. 2024;106:195-199.
    >> Share

  98. HAMANO T, Fukagawa M
    Results of the EPISODE trial plead for reasonable practice-based serum phosphate lowering in patients on dialysis.
    Kidney Int. 2024;106:191-195.
    >> Share

    July 2024
  99. ROSE M, Fischer FH, Liegl G, Strippoli GF, et al
    The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration.
    Kidney Int. 2024 Jul 30:S0085-2538(24)00534-9. doi: 10.1016/j.kint.2024.
    >> Share

  100. ZIMMERMANN S, Mathew A, Bondareva O, Elwakiel A, et al
    Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain.
    Kidney Int. 2024 Jul 30:S0085-2538(24)00535-0. doi: 10.1016/j.kint.2024.
    >> Share

  101. JOHNSON RJ, Mandell BF, Schlessinger N, Mount DB, et al
    Controversies and practical management of patients with gout and chronic kidney disease.
    Kidney Int. 2024 Jul 19:S0085-2538(24)00473-3. doi: 10.1016/j.kint.2024.
    >> Share

  102. STAMELLOU E, Noels H, Floege J
    Factor XI inhibition in hemodialysis patients: the safer anticoagulation?
    Kidney Int. 2024;106:21-23.
    >> Share

  103. SAHINOZ M, Ikizler TA
    Inflammasome activation: unraveling the link between chronic kidney disease and atrial fibrillation.
    Kidney Int. 2024;106:6-9.
    >> Share

  104. MEDINA RANGEL PX, Ishibe S
    Preventing MMP23-mediated cleavage of podocyte RARRES1: a novel strategy to halt chronic kidney disease progression?
    Kidney Int. 2024;106:16-18.
    >> Share

  105. WONG G, Guha C, Mallitt KA, van Zwieten A, et al
    The randomized controlled trial (NAVKIDS2) of a patient navigator program created for children with chronic kidney disease.
    Kidney Int. 2024 Jul 1:S0085-2538(24)00450-2. doi: 10.1016/j.kint.2024.
    >> Share

    May 2024
  106. CORKEN AL, Ong V, Kore R, Ghanta SN, et al
    Platelets, Inflammation, and Purinergic Receptors in Chronic Kidney Disease.
    Kidney Int. 2024 May 29:S0085-2538(24)00381-8. doi: 10.1016/j.kint.2024.
    >> Share

  107. CHAN GC, Kalantar-Zadeh K, Ng JK, Tian N, et al
    Frailty in Patients on Dialysis.
    Kidney Int. 2024 May 3:S0085-2538(24)00315-6. doi: 10.1016/j.kint.2024.
    >> Share

  108. GOLDSTEIN CE, Taljaard M, Nicholls SG, Beaucage M, et al
    The Ottawa Statement implementation guidance document for cluster randomized trials in the hemodialysis setting.
    Kidney Int. 2024;105:898-911.
    >> Share

  109. CULLIS B, McCulloch M, Finkelstein FO
    Development of PD in lower-income countries: a rational solution for the management of AKI and ESKD.
    Kidney Int. 2024;105:953-959.
    >> Share

    April 2024
  110. WONG G, Bernier-Jean A, Rovin B, Ronco P, et al
    Time for Action: Recognising chronic kidney disease as a major non-communicable disease driver of premature mortality.
    Kidney Int. 2024 Apr 2:S0085-2538(24)00247-3. doi: 10.1016/j.kint.2024.
    >> Share


  111. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
    Kidney Int. 2024;105.
    >> Share

  112. LEVIN A, Ahmed SB, Carrero JJ, Foster B, et al
    Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
    Kidney Int. 2024;105:684-701.
    >> Share

    March 2024
  113. WINKELMAYER WC, Lensing AWA, Thadhani RI, Mahaffey KW, et al
    A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis.
    Kidney Int. 2024 Mar 25:S0085-2538(24)00196-0. doi: 10.1016/j.kint.2024.
    >> Share

  114. PIETERS TT, Besseling PJ, Bovee DM, Rookmaaker MB, et al
    Discrepancies between transcutaneous and estimated glomerular filtration rates in rats with chronic kidney disease.
    Kidney Int. 2024 Mar 19:S0085-2538(24)00187-X. doi: 10.1016/j.kint.2024.
    >> Share

  115. GILL JS, Chadban SJ
    Pretransplant screening for coronary artery disease: data are required before practice change.
    Kidney Int. 2024;105:470-472.
    >> Share

    February 2024
  116. LEE J, Lee J, Kim K, Lee J, et al
    Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.
    Kidney Int. 2024 Feb 29:S0085-2538(24)00163-7. doi: 10.1016/j.kint.2024.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016